Skip to content
FDAMedicines

BD Issues Nationwide Recall for Specific Lots of ChloraPrep™ Clear Single Sterile 1 mL and FREPP™ Clear 1.5 mL Applicators Due to Microbial Contamination

FDA recall n-bd-issues-nationwide-recall-specific-lots-chlorapreptm-clear-single-sterile-1-ml ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Potential fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides
Text from FDA, unedited.

The recalled product

Codes in the record. Click one to copy it.

FRANKLIN LAKES, N.J. (June 06, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling lot 4032183 of ChloraPrep™ Clear 1 mL Single Sterile and lot 4073005 of FREPP™ Clear 1.5 mL applicators with paper lidding to the consumer level. These products are being recalled due to fungal contami
Text from FDA, unedited.

Company announcement, as FDA publishes it

FRANKLIN LAKES, N.J. (June 06, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling lot 4032183 of ChloraPrep™ Clear 1 mL Single Sterile and lot 4073005 of FREPP™ Clear 1.5 mL applicators with paper lidding to the consumer level. These products are being recalled due to fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides.

These two impacted lots were shipped to distributors and hospitals between March 2024 through June 2024.

Risk Statement: Contamination of skin preparation products with Aspergillus penicillioides may lead to serious systemic infection, sepsis, illness, and death. If the fungus is introduced in the patient’s bloodstream during placement of an intravascular catheter, the catheter would most likely have to be removed, necessitating another procedure. Aspergillus penicillioides infection of a surgical site may result in the need for medical and surgical interventions and long-term treatment with antifungal drugs. Importantly, BD has not received any reports of adverse events related to this recall.

In addition, BD is recalling other lots out of an abundance of caution as outlined in the customer letter .

These products are packaged in a pouch with paper lidding and used for the preparation of the patient’s skin prior to procedures, to help reduce bacteria that potentially can cause skin infection.

The affected lots can be identified by locating the referenced catalog and lot numbers on the lidding of the product package and the side of the inner carton as shown in the customer letter.

BD is notifying its customers and distributors who received this product directly. Customers and distributors should immediately discontinue use of and destroy all affected units in accordance with their facility’s process.

BD will issue replacement for destroyed product of the affected lot numbers to customers that purchased the affected product directly from BD, following receipt of the completed Customer Response Form.

Customer inquiries related to this recall, as well as adverse reaction/events experienced with the product, should be addressed to BD’s North American Regional Complaint Center: 1-844-823-5433 (Toll Free) Monday – Friday between the hours of 8a.m. and 5 p.m. CT or by emailing: productcomplaints@bd.com .

FDA MedWatch Reporting

Adverse reactions/events experienced with the use of any of these products should also be reported to the FDA's MedWatch Adverse Event Reporting program either online, phone or by regular mail.

Complete and submit the report Online : www.fda.gov/medwatch/report.htm

Call 1-800-FDA-1088 (1-800-332-1088)

Regular Mail : MedWatch, HF-2, FDA, 5600 Fisher’s Lane, Rockville, MD 20852-9787

The U.S. Food and Drug Administration (FDA) has been notified of this recall.

# # #

About BD BD is one of the world’s largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X @BDandCo or Instagram @becton_dickinson .

Text from FDA (the company’s words), unedited.
  • BD ChloraPrep™ Clear - 1 mL Applicators 60 Applicators per Inner Carton

    Lot or code
    Affected ; Product NDC: 54365-400-31; Catalog (REF) ; Number: 930480; Lot ; Number: 4032183; Expiry ; Date: 01/31/2027
  • BD ChloraPrep™ FREPP™ Clear 1.5 mL Applicators 20 Applicators per Inner Carton

    Lot or code
    Affected ; Product NDC: 54365-400-30; Catalog (REF) ; Number: 930299; Lot ; Number: 4073005; Expiry ; Date: 03/31/2027

Source

Issued by
U.S. Food and Drug Administration
Firm
BD

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: BD, Month: June 2026, Week 2026-W23. Browse more medicines recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Potential fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published this company announcement on June 6, 2026.

Other notices of BD